2 documents found, page 1 of 1
Remdesivir and corticosteroids in the treatment of hospitalized COVID-19 patients
Coelho, Luís; Falcão, Fatima; Povoa, Pedro; Viegas, Erica; Martins, Antonio Pais; Carmo, Eduarda; Fonseca, Candida; Campos, Luis; Mansinho, Kamalok; Coronavirus disease 2019 (COVID-19) is a pandemic infection caused by the newly discovered severe acute respiratory syndrome coronavirus 2. Remdesivir (RDV) and corticosteroids are used mainly in COVID-19 patients with acute respiratory failure. The main objective of the study was to assess the effectiveness of remdesivir with and without corticosteroids in the treatment of COVID-19 patients. We conducted a...
A prospective, observational study to evaluate adverse drug reactions in patien...
Falcão, Fátima; Viegas, Erica; Carmo, Ines; Soares, Joana; Falcao, Margarida; Solano, Mariana; Cavaco, Patricia; Mendes, Dina; Rijo, João; Povoa, Pedro© European Association of Hospital Pharmacists 2021. No commercial re-use. See rights and permissions. Published by BMJ.; OBJECTIVES: Since the outbreak of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), the pressure to minimise its impact on public health has led to the implementation of different therapeutic strategies, the efficacy of which for the treatment of coronavirus disease 2019 (COVID-1...